Emmessar Biotech & Nutrition quarterly results and financials

Emmessar Biotech & Nutrition (BSE 524768)₹23.98+6.63%(9 Nov 2026 close)Commodity Chemicals

Key facts

In the Jun 2026 quarter (standalone), Emmessar Biotech & Nutrition reported sales of ₹0.07 Cr, down 30.0% from Jun 2025, and net profit of ₹0.14 Cr, down 22.2% year on year. For the year to Mar 2026, sales were ₹0.38 Cr and net profit ₹0.45 Cr.

Sales (Jun 2026): ₹0.07 Cr
Net profit (Jun 2026): ₹0.14 Cr
Sales (FY Mar 2026): ₹0.38 Cr
Net profit (FY Mar 2026): ₹0.45 Cr
EPS (Jun 2026): ₹0.27
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Emmessar Biotech & Nutrition quarterly results

₹ crore unless stated; each column is a quarter.

Emmessar Biotech & Nutrition Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.09	0.34	0.09	0.09	0.35	0.11	0.11	0.10	0.10	0.10	0.10	0.07
Expenses	0.31	0.55	0.48	0.37	0.43	0.39	0.44	0.37	0.47	0.44	0.47	0.42
Operating Profit	−0.23	−0.22	−0.40	−0.29	−0.09	−0.29	−0.34	−0.28	−0.38	−0.35	−0.38	−0.36
OPM %	−274.9%	−63.5%	−487.4%	−349.9%	−23.5%	−279.9%	−329.9%	−300.0%	−411.1%	−377.7%	−411.1%	−583.3%
Other Income	0.54	0.54	0.49	0.47	0.52	0.44	0.62	0.54	0.55	0.50	0.48	0.55
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.03
Profit before tax	0.30	0.31	0.08	0.17	0.42	0.14	0.27	0.25	0.15	0.13	0.08	0.18
Tax %	31.0%	56.7%	−285.7%	43.8%	31.7%	84.6%	126.9%	25.0%	21.4%	8.3%	57.2%	17.6%
Net Profit	0.21	0.14	0.28	0.10	0.29	0.03	−0.08	0.18	0.12	0.13	0.04	0.14
EPS (Rs)	0.41	0.27	0.55	0.19	0.57	0.05	−0.15	0.35	0.23	0.25	0.07	0.27

Emmessar Biotech & Nutrition profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Emmessar Biotech & Nutrition Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	1.99	2.62	1.28	0.64	3.41	7.01	0.37	1.03	0.57	0.62	0.38	0.37
Expenses	2.67	2.39	1.68	1.28	3.82	6.16	1.27	1.72	1.65	1.57	1.74	1.80
Operating Profit	−0.69	0.24	−0.41	−0.65	−0.42	0.85	−0.91	−0.70	−1.09	−0.96	−1.37	−1.47
OPM %	−34.3%	8.9%	−31.4%	−101.5%	−12.0%	12.1%	−249.9%	−67.6%	−192.8%	−155.7%	−367.5%	−397.3%
Other Income	0.04	0.99	1.26	1.02	1.22	1.48	1.93	1.76	2.00	2.02	2.05	2.08
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.04	0.02	0.06	0.09	0.07	0.07	0.10	0.10	0.11	0.11	0.11	0.15
Profit before tax	−0.69	1.20	0.81	0.30	0.75	2.26	0.94	0.98	0.82	0.97	0.59	0.54
Tax %	−30.9%	0.0%	−15.0%	−82.8%	−2.7%	36.0%	48.4%	47.4%	7.4%	66.7%	24.2%	—
Exceptional items	−0.24	0.00	0.00	−0.24	−0.20	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−0.48	1.20	0.92	0.54	0.76	1.46	0.49	0.51	0.76	0.33	0.45	0.43
EPS (Rs)	−0.95	2.39	1.83	1.07	1.51	2.91	0.97	1.01	1.51	0.65	0.89	0.82
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Emmessar Biotech & Nutrition balance sheet

₹ crore, at each year end.

Emmessar Biotech & Nutrition Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5.01	4.99	5.01	5.01	4.99	5.00	4.98	4.98	4.98	4.98	4.98	4.98
Reserves	−3.63	−4.11	−2.92	−2.02	−1.50	−0.74	0.70	1.16	1.67	2.40	2.70	3.11
Borrowings	0.00	0.00	0.00	0.00	0.07	0.00	0.00	0.00	0.08	0.11	0.00	0.00
Other Liabilities	1.02	1.36	1.13	0.91	1.58	1.85	2.09	1.03	1.18	1.23	1.49	1.40
Total Liabilities	2.40	2.24	3.22	3.90	5.14	6.11	7.77	7.17	7.91	8.72	9.17	9.49
Fixed Assets	1.41	0.72	0.71	2.24	1.98	1.90	1.85	2.06	1.99	1.90	1.80	1.71
CWIP	0.00	0.00	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.02	0.00	0.02	0.02	0.00	0.02	0.00	0.00	0.02	0.02	0.00	0.02
Other Assets	0.97	1.52	1.68	1.64	3.16	4.19	5.92	5.11	5.90	6.80	7.37	7.76
Inventories	0.70	0.37	0.33	0.10	0.74	1.16	0.08	0.08	0.15	0.10	0.13	0.11
Trade receivables	0.05	0.35	0.05	0.04	0.05	0.02	2.70	0.00	0.00	0.01	0.01	0.01
Cash & equivalents	0.03	0.44	0.33	0.28	0.72	1.89	2.48	4.59	5.20	6.19	6.88	7.34
Total Assets	2.40	2.24	3.22	3.90	5.14	6.11	7.77	7.17	7.91	8.72	9.17	9.49

Emmessar Biotech & Nutrition cash flow

₹ crore, for each year.

Emmessar Biotech & Nutrition Cash flow
	Mar 2015	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.00	0.74	0.73	0.38	1.02	0.46	2.26	0.37	0.63	0.21	0.26
Cash from investing activity	0.00	−0.75	−0.68	−0.36	−1.07	0.00	−2.60	−0.54	−0.63	−0.22	−0.25
Cash from financing activity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net cash flow	0.00	0.00	0.06	0.00	−0.02	0.47	−0.33	−0.16	0.00	0.00	0.01
Capex	0.00	0.00	0.77	0.00	0.00	0.00	0.30	0.02	0.00	0.00	0.00
Free cash flow	−0.02	−0.07	−0.05	0.40	1.04	0.48	1.97	0.36	0.65	0.23	0.27
CFO / OP %	7.0%	343.0%	−197.9%	−61.0%	−250.9%	68.0%	−283.9%	−46.0%	−56.9%	−24.9%	−10.9%

Emmessar Biotech & Nutrition ratios

Working-capital days and returns, by year.

Emmessar Biotech & Nutrition Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	6	65	5	8	22	2	141	9	3	12	11	19
Inventory days	336	137	122	52	2,050	273	7	197	128	164	231	406
Days payable	152	77	77	7	1,629	191	53	57	0	19	0	42
Cash conversion cycle	192	127	51	55	444	86	97	151	131	159	242	385
Working capital days	38	22	85	175	458	30	79	−61	115	91	36	99
ROCE %	−10.8%	−39.3%	80.0%	31.5%	17.7%	25.5%	45.1%	15.7%	15.0%	11.4%	12.6%	7.3%

Emmessar Biotech & Nutrition: frequently asked questions

What are the latest quarterly results of Emmessar Biotech & Nutrition?

For the Jun 2026 quarter, Emmessar Biotech & Nutrition reported sales of ₹0.07 Cr, down 30.0% year on year and net profit of ₹0.14 Cr, down 22.2% year on year. The operating margin was −583.3%.

What is the annual revenue of Emmessar Biotech & Nutrition?

Emmessar Biotech & Nutrition's sales for the year to Mar 2026 were ₹0.38 Cr; over the last twelve months they were ₹0.37 Cr.

What is the net profit of Emmessar Biotech & Nutrition?

Net profit for the year to Mar 2026 was ₹0.45 Cr, and ₹0.43 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.82.

How much debt does Emmessar Biotech & Nutrition have?

Emmessar Biotech & Nutrition reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹7.34 Cr.

What is the free cash flow of Emmessar Biotech & Nutrition?

Cash from operations was ₹0.26 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.27 Cr.

Loading…